National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2013-03-03
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 04:01:22

Label at a glance#

RxCUI, Display, Full name table
RxCUI	Display	Full name	Type	Form / route
1251290	UROGESIC BLUE REFORMULATED APR 2012 (Oral Pill)	hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urogesic Blue Reformulated Apr 2012]	SBD Active

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0485-0151-01	EA - Each	0485-0151	b6d2b268-e65b-455d-ae8b-87dfc7c59fdb	1	2013-03-03

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0485-0151	0485-0151-01

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
UROGESIC BLUE	METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE	EDWARDS PHARMACEUTICALS, INC.	f650dd78-615c-42d3-9b2d-3a989039d80c	2026-03-05	Warnings, Adverse reactions	Exact identifier ndc (package): 0485-0151-01 ndc11 (package): 00485015101

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.